Market Research

Facial Injectables Market (Product Type: Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymethylmethacrylate Beads (PMMA Microspheres), Poly-L-Lactic Acid (PLLA), and Others) - Global Industry Analysis, Size, Share, G

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 150 Pages Transparency Market Research Pvt. Ltd. June, 2023 TNPR18094200
Best Price Guarantee
Price from $5,795
Length 150 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date June, 2023
SKU TNPR18094200

Facial Injectables Market (Product Type: Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymethylmethacrylate Beads (PMMA Microspheres), Poly-L-Lactic Acid (PLLA), and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Facial Injectables Market – Scope of Report


TMR’s report on the global Facial Injectables Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Facial Injectables Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Facial Injectables Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Facial Injectables Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Facial Injectables Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Facial Injectables Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Facial Injectables Market.

The report delves into the competitive landscape of the global Facial Injectables Market. Key players operating in the global Facial Injectables Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Facial Injectables Market profiled in this report.

Key Questions Answered in Global Facial Injectables Market Report
  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Facial Injectables Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Facial Injectables Market – Research Objectives and Research Approach

The comprehensive report on the global Facial Injectables Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Facial Injectables Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Facial Injectables.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Facial Injectables Market
4. Market Overview
  4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
  4.5. Porter’s Five Forces Analysis
5. Key Insights
  5.1. Technological Advancements
  5.2. Pricing Analysis
  5.3. Key Mergers & Acquisitions
  5.4. Top 3 Players Operating in the Market Space
  5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Facial Injectables Market Analysis and Forecast, by Product Type
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Collagen
6.3.2. Hyaluronic Acid (HA)
6.3.3. Botulinum Toxin Type A
6.3.4. Calcium Hydroxylapatite (CaHA)
6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)
6.3.6. Poly-L-Lactic Acid (PLLA)
6.3.7. Others (Polyalkylimide )
  6.4. Market Attractiveness Analysis, by Product Type
7. Global Facial Injectables Market Analysis and Forecast, by Application
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Facial Line Correction
7.3.2. Lip Augmentation
7.3.3. Acne Scar Treatment
7.3.4. Face Lift
7.3.5. Lipoatrophy Treatment
7.3.6. Others (earlobe rejuvenation)
  7.4. Market Attractiveness Analysis, by Application
8. Global Facial Injectables Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Others (beauty clinics)
  8.4. Market Attractiveness Analysis, by End-user
9. Global Facial Injectables Market Analysis and Forecast, by Region
  9.1. Key Findings
  9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
  9.3. Market Attractiveness Analysis, by Region
10. North America Facial Injectables Market Analysis and Forecast
  10.1. Introduction
10.1.1. Key Findings
  10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Collagen
10.2.2. Hyaluronic Acid (HA)
10.2.3. Botulinum Toxin Type A
10.2.4. Calcium Hydroxylapatite (CaHA)
10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
10.2.6. Poly-L-Lactic Acid (PLLA)
10.2.7. Others (Polyalkylimide)
  10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Facial Line Correction
10.3.2. Lip Augmentation
10.3.3. Acne Scar Treatment
10.3.4. Face Lift
10.3.5. Lipoatrophy Treatment
10.3.6. Others (earlobe rejuvenation)
  10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Others (Beauty Clinics)
  10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
  10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Facial Injectables Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Collagen
11.2.2. Hyaluronic Acid (HA)
11.2.3. Botulinum Toxin Type A
11.2.4. Calcium Hydroxylapatite (CaHA)
11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
11.2.6. Poly-L-Lactic Acid (PLLA)
11.2.7. Others (Polyalkylimide)
  11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Facial Line Correction
11.3.2. Lip Augmentation
11.3.3. Acne Scar Treatment
11.3.4. Face Lift
11.3.5. Lipoatrophy Treatment
11.3.6. Others (earlobe rejuvenation)
  11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Others (beauty clinics)
  11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
  11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Facial Injectables Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Collagen
12.2.2. Hyaluronic Acid (HA)
12.2.3. Botulinum Toxin Type A
12.2.4. Calcium Hydroxylapatite (CaHA)
12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
12.2.6. Poly-L-Lactic Acid (PLLA)
12.2.7. Others (Polyalkylimide)
  12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Facial Line Correction
12.3.2. Lip Augmentation
12.3.3. Acne Scar Treatment
12.3.4. Face Lift
12.3.5. Lipoatrophy Treatment
12.3.6. Others (earlobe rejuvenation)
  12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Others (beauty clinics)
  12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
  12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Facial Injectables Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Collagen
13.2.2. Hyaluronic Acid (HA)
13.2.3. Botulinum Toxin Type A
13.2.4. Calcium Hydroxylapatite (CaHA)
13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
13.2.6. Poly-L-Lactic Acid (PLLA)
13.2.7. Others (Polyalkylimide)
  13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Facial Line Correction
13.3.2. Lip Augmentation
13.3.3. Acne Scar Treatment
13.3.4. Face Lift
13.3.5. Lipoatrophy Treatment
13.3.6. Others (earlobe rejuvenation)
  13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Others (beauty clinics)
  13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
  13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Facial Injectables Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Collagen
14.2.2. Hyaluronic Acid (HA)
14.2.3. Botulinum Toxin Type A
14.2.4. Calcium Hydroxylapatite (CaHA)
14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
14.2.6. Poly-L-Lactic Acid (PLLA)
14.2.7. Others (Polyalkylimide)
  14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Facial Line Correction
14.3.2. Lip Augmentation
14.3.3. Acne Scar Treatment
14.3.4. Face Lift
14.3.5. Lipoatrophy Treatment
14.3.6. Others (earlobe rejuvenation)
  14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Dermatology Clinics
14.4.3. Others (beauty clinics)
  14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
  14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competition Matrix (by tier and size of companies)
  15.2. Market Share Analysis, by Company (2021)
  15.3. Company Profiles
15.3.1. Allergan, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Ipsen (Mayroy SA)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Merz Pharma
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Suneva Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Medytox Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Sinclair Pharma
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Bloomage BioTechnology
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Anika Therapeutics, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Prollenium Medical Technologies
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Galderma
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings